IIQ INOVIQ Ltd

ASX · AU · Healthcare · Life Science Tools · inoviq.com

—Mkt Cap: —P/E: —1d ago

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocyto…

Key Statistics

Company

Market Cap—

Enterprise Value6.87M USD

Revenue (TTM)1.53M USD

Gross Profit245.57K USD

Net Income (TTM)-5.19M USD

Revenue/Share0.02 AUD

Last Price—

Fiscal Year EndJun 2026

MR QuarterJun 2026

Employees—

CountryAU

SectorHealthcare

IndustryLife Science Tools

ISINAU0000196149

Valuation

P/E (Trailing)—

P/E (Forward)13.50

PEG—

EV/EBITDA-1.48

EV/Revenue4.49

P/S8.58

P/B1.01

EPS (TTM)-0.06

EPS (Forward)0.01

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin82.25%

Oper. Margin-343.78%

EBITDA Margin0.00%

Profit Margin-1737.11%

ROE-39.73%

ROA-36.70%

Growth

Revenue Growth11.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-4.41M USD

CapEx (TTM)116.33K USD

FCF Margin-190.01%

FCF Yield—

Net Debt-6.26M USD

Net Debt/EBITDA1.35

Balance Sheet

Debt/Equity0.02

Current Ratio9.37

Quick Ratio9.06

Book Value/Sh0.13 AUD

Cash/Share0.07 AUD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 AUD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:30

Split DateDec 1, 2020

Analyst Consensus

Rating—

Target (Mean)0.7000 AUD

Target Range0.7000 AUD – 0.7000 AUD

# Analysts1

Ownership

Shares Out.140.78M

Float118.88M

Insiders33.95%

Institutions7.00%

Technical

SMA 500.1745 AUD

SMA 2000.2900 AUD

Beta1.48

S&P 52W Chg16.44%

Avg Vol (30d)—

Avg Vol (10d)94.07K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—

IIQ INOVIQ Ltd

Industry Peers

Key Statistics